Stieber P

No ORCID on file · 4 papers in corpus
article 2011
The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses
Clinical chemistry and laboratory medicine ·doi:10.1515/cclm.2011.709

BACKGROUND: Cancer antigen 125 (CA125) is the best known single tumor marker for ovarian cancer (OC). We investigated whether the additional information of the human epididymis protein 4 (HE4) improves diagnostic accuracy. METHODS: We retro…

other 2009
Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology ·doi:10.1158/1055-9965.EPI-08-0653

Comparative proteomics identified the vitamin E-binding plasma protein afamin as a potential novel tumor marker for ovarian cancer. In addition, we observed in a previous small study decreased plasma concentrations of apolipoprotein A-IV (a…

other 2009
Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors
Clinical chemistry and laboratory medicine ·doi:10.1515/CCLM.2009.134

BACKGROUND: The aim of this study was to assess the prognostic value of cancer antigen (CA) 125 and CA 72-4 in patients with ovarian borderline tumor (BOT). METHODS: All women diagnosed and treated for BOT at our institution between 1981 a…

2006
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA.
Cancer immunology, immunotherapy : CII ·doi:10.1007/s00262-006-0167-1

Expression of ligands of the immunoreceptor NKG2D such as MICA and MICB has been proposed to play an important role in the immunosurveillance of tumors. Proteolytic shedding of NKG2D ligands from cancer cells therefore constitutes an immune…